FiercePharma8d
After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication
In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...
GSK Class Action News: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Involving GSK PLC
SAN DIEGO, CA / ACCESS Newswire / February 10, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
Morningstar8d
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action
In April 2020, the FDA requested that manufacturers cease selling Zantac and any generic alternatives. The complaint alleges that during the class period, defendants misrepresented the reasons ...
Macau Business9d
GSK sees annual profit slide on Zantac drug fallout
British pharmaceutical group GSK on Wednesday reported a near halving of net profit in 2024 after settling hefty US lawsuits over its Zantac heartburn drug.